Intracochlear drug delivery systems: a novel approach whose time has come

References

• Ayoob AM, Borenstein JT. The role of intracochlear drug delivery devices in the management of inner ear disease. Expert Opin Drug Deliv. 2015;12(3):465–479.
   PubMed Web of Science ®Google Scholar
• Holley MC. Keynote review: the auditory system, hearing loss and potential targets for drug development. Drug Discov Today. 2005;10(19):1269–1282.
   PubMed Web of Science ®Google Scholar
• Plontke SK, Siedow N, Wegener R, et al. Cochlear pharmacokinetics with local inner ear drug delivery using a three-dimensional finite-element computer model. Audiol Neurootol. 2007;12(1): 37–48. PMCID: 1779502.
   PubMed Web of Science ®Google Scholar
• Breglio AM, Rusheen AE, Shide ED, et al. Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nat Commun. 2017;8(1):1654. PMCID: 5698400.
   PubMed Web of Science ®Google Scholar
• Crowson MG, Hertzano R, Tucci DL. Emerging therapies for sensorineural hearing loss. Otol Neurotol. 2017;38(6): 792–803. PMCID: 5465007.
   PubMed Web of Science ®Google Scholar
• Suckfuell M, Lisowska G, Domka W, et al. Efficacy and safety of AM-111 in the treatment of acute sensorineural hearing loss: a double-blind, randomized, placebo-controlled phase II study. Otol Neurotol. 2014;35(8):1317–1326.
   PubMed Web of Science ®Google Scholar
• Oishi N, Schacht J. Emerging treatments for noise-induced hearing loss. Exp Opin Emerg Drugs. 2011;16(2): 235–245. PMCID: 3102156.
   PubMed Web of Science ®Google Scholar
• Mizutari K, Fujioka M, Hosoya M, et al. Notch inhibition induces cochlear hair cell regeneration and recovery of hearing after acoustic trauma. Neuron. 2013;77(1):58–69. PMCID: 3573859.
   PubMed Web of Science ®Google Scholar
• McLean WJ, Yin X, Lu L, et al. Clonal expansion of Lgr5-positive cells from mammalian cochlea and high-purity generation of sensory hair cells. Cell Rep. 2017;18(8):1917–1929. PMCID: 5395286.
   PubMed Web of Science ®Google Scholar
• Suzuki J, Corfas G, Liberman MC. Round-window delivery of neurotrophin 3 regenerates cochlear synapses after acoustic overexposure. Sci Rep. 2016;6: 24907. PMCID: 4842978.
   PubMed Web of Science ®Google Scholar
• Zhou QQ, Dai YH, Du XP, et al. Aminophylline restores glucocorticoid sensitivity in a guinea pig model of sudden sensorineural hearing loss induced by lipopolysaccharide. Sci Rep. 2017;7(1): 2736. PMCID: 5457401.
   PubMedGoogle Scholar
• Pararas EE, Borkholder DA, Borenstein JT. Microsystems technologies for drug delivery to the inner ear. Adv Drug Deliv Rev. 2012;64(14): 1650–1660. PMCID: 3387506.
   PubMed Web of Science ®Google Scholar
• Brown JN, Miller JM, Altschuler RA, et al. Osmotic pump implant for chronic infusion of drugs into the inner ear. Hear Res. 1993;70(2):167–172.
   PubMed Web of Science ®Google Scholar
• Staecker H, Jolly C, Garnham C. Cochlear implantation: an opportunity for drug development. Drug Discov Today. 2010;15(7–8):314–321.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Cardoso L, Lalwani AK, et al. A dual wedge microneedle for sampling of perilymph solution via round window membrane. Biomed Microdevices. 2016;18(2): 24. PMCID: 5574191.
   PubMed Web of Science ®Google Scholar
• Borkholder DA, Zhu X, Hyatt BT, et al. Murine intracochlear drug delivery: reducing concentration gradients within the cochlea. Hear Res. 2010;268(1–2): 2–11. PMCID: 2933796.
   PubMed Web of Science ®Google Scholar
• Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and laboratory evaluation. Otol Neurotol. 2001;22(1):18–23.
   PubMed Web of Science ®Google Scholar
• Suckfuell M, Canis M, Strieth S, et al. Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: a prospective randomized phase I/II study. Acta Otolaryngol. 2007;127(9):938–942.
   PubMed Web of Science ®Google Scholar
• van de Water TR, Staecker H, Halterman MW, et al. Gene therapy in the inner ear. Mechanisms and clinical implications. Ann N Y Acad Sci. 1999;884:345–360.
   PubMed Web of Science ®Google Scholar
• Goycoolea MV. Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol. 2001;121(4):437–447.
   PubMed Web of Science ®Google Scholar
• Juhn SK, Hamaguchi Y, Goycoolea M. Review of round window membrane permeability. Acta Otolaryngol Suppl. 1989;457:43–48.
   PubMedGoogle Scholar
• Tandon V, Kang WS, Robbins TA, et al. Microfabricated reciprocating micropump for intracochlear drug delivery with integrated drug/fluid storage and electronically controlled dosing. Lab Chip. 2016;16(5):829–846. PMCID: 4766044.
   PubMed Web of Science ®Google Scholar
• Tandon V, Kang WS, Spencer AJ, et al. Microfabricated infuse-withdraw micropump component for an integrated inner-ear drug-delivery platform. Biomed Microdevices. 2015;17(2):37.
   PubMed Web of Science ®Google Scholar
• Chen Z, Kujawa SG, McKenna MJ, et al. Inner ear drug delivery via a reciprocating perfusion system in the guinea pig. J Control Release. 2005;110(1):1–19. PMCID: 2030590.
   PubMed Web of Science ®Google Scholar
• Sewell WF, Borenstein JT, Chen Z, et al. Development of a microfluidics-based intracochlear drug delivery device. Audiol Neurootol. 2009;14(6):411–422. PMCID: 2820330.
   PubMed Web of Science ®Google Scholar
• Chirtes F, Albu S. An overview of pharmacology and clinical aspects concerning the therapy of cochleo-vestibular syndromes by intratympanic drug delivery. Clujul Med. 2013;86(3): 185–191. PMCID: 4462510.
   PubMedGoogle Scholar
• Plontke SK, Hartsock JJ, Gill RM, et al. Intracochlear drug injections through the round window membrane: measures to improve drug retention. Audiol Neurootol. 2016;21(2): 72–79. PMCID: 4842307.
   PubMed Web of Science ®Google Scholar
• Salt AN, Hartsock JJ, Gill RM, et al. Perilymph pharmacokinetics of locally-applied gentamicin in the guinea pig. Hear Res. 2016;342: 101–111. PMCID: 5121026.
   PubMed Web of Science ®Google Scholar